Cargando…

Effective sickle hemoglobin reduction by automated red cell exchange using Spectra Optia in three Emirati patients with sickle cell disease before allogeneic hematopoietic stem cell transplantation

Detalles Bibliográficos
Autores principales:	Choi, Seung Jun, Cho, Hanwool, Eom, Ki-Seong, Lee, Jong Wook, Kim, Yonggoo, Lim, Jihyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300674/ https://www.ncbi.nlm.nih.gov/pubmed/30588471 http://dx.doi.org/10.5045/br.2018.53.4.325

Ejemplares similares

Spectra Optia(®) for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance
por: Willits, Iain, et al.
Publicado: (2017)

PB2527: COMPARING REAL-LIFE VERSUS PREDICTED PARAMETERS WITH OPTIA SPECTRA IN RED BLOOD CELL EXCHANGE IN SICKLE-CELL DISEASE PATIENTS
por: Rumschisky, Pablo Palomo, et al.
Publicado: (2023)

Therapeutic Plasma Exchange Using the Spectra Optia Cell Separator Compared With the COBE Spectra
por: Kim, Do-kyun, et al.
Publicado: (2015)

Automated Red Cell Exchange in the Management of Sickle Cell Disease
por: Tsitsikas, Dimitris A., et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

Role of Emergency Automated Red Cell Exchange in Sickle Cell Crisis: A Case Report
por: Gupta, Anubhav, et al.
Publicado: (2020)

Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion
por: Ebraheem, Mohammad S., et al.
Publicado: (2021)

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
por: De Souza, Daniel C., et al.
Publicado: (2023)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion
por: Adkins, Brian D., et al.
Publicado: (2019)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Hemoglobin level and macular thinning in sickle cell disease
por: Hussnain, S Amal, et al.
Publicado: (2019)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

THE STATE OF HEMOGLOBIN IN SICKLED ERYTHROCYTES
por: Stetson, Chandler A.
Publicado: (1966)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection
por: Lee, Se-Na, et al.
Publicado: (2017)

Treatment of Priapism with Automated Red Cell Exchange and Hyperbaric Oxygen in an 11-year-old Patient with Sickle Cell Disease
por: Azık, Fatih Mehmet, et al.
Publicado: (2012)

Manual red cell exchange transfusion to avert sickle cell related complications
por: Mehra, Ruhi A., et al.
Publicado: (2018)

Red blood cell exchange in sickle cell disease patient with multiple alloantibodies
por: Aggarwal, Geet, et al.
Publicado: (2020)

A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells
por: Nakagawa, Akito, et al.
Publicado: (2018)

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
por: Eridani, Sandro, et al.
Publicado: (2011)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
por: Rab, Minke A.E., et al.
Publicado: (2019)

The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts
por: Lopert, Pamela, et al.
Publicado: (2022)

THE PHYSICAL STATE OF HEMOGLOBIN IN SICKLE-CELL ANEMIA ERYTHROCYTES IN VIVO
por: Döbler, Johanna, et al.
Publicado: (1968)

Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease
por: El Hoss, Sara, et al.
Publicado: (2020)

Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease
por: Ershler, William B., et al.
Publicado: (2023)

Elastic property of sickle cell anemia and sickle cell trait red blood cells
por: Muhammed, Endris, et al.
Publicado: (2021)

Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease
por: Vunnam, Nagamani, et al.
Publicado: (2022)

Substitutions in the β subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation
por: Meng, Fantao, et al.
Publicado: (2019)

A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
por: Veludhandi, Anirudh, et al.
Publicado: (2021)

An “acquired” hemoglobin J variant in a sickle cell disease patient
por: Swedan, Nawwar, et al.
Publicado: (2008)

The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
por: Castro, O., et al.
Publicado: (1974)

Fetal hemoglobin level and nutritional status in patients with sickle cell disease
por: Badawy, Sherif M.
Publicado: (2016)

Human hemoglobin G-Makassar variant masquerading as sickle cell anemia
por: Mohamad, Ahmad Sabry, et al.
Publicado: (2018)

The curious case of hemoglobin DC disease masquerading as sickle cell anemia
por: Hirani, Samina, et al.
Publicado: (2020)

Unrecognized hemoglobin SC sickle cell disease complicated by sepsis and cholestasis
por: McFarland, Thomas, et al.
Publicado: (2022)

Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease
por: Yenamandra, Avani, et al.
Publicado: (2020)

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease
por: Pavan, Aline Renata, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htt9c3vh9q987d5r4jtp2m4mjh